Learn more about how EXCITE International, a not-for-profit organization, can help your medical technology company navigate the notoriously complex pathway from innovation to adoption through a single streamlined EXCITE pathway to global adoption.
The is an information session that will form the basis for companies to apply to EXCITE International for evaluation of their medical technology. It will also offer an opportunity for an open discussion on the EXCITE International model by policy makers
EXCITE International has assembled one of the largest comprehensive infrastructures across the U.S. and Canada and working to consolidate its positioning with the U.K., Netherlands and Norway. Through the multinational collaboration between industry, regulators, payers, health systems, governments, patients, and expert end-users early on in the selection and evaluation process, EXCITE International is poised to expedite global adoption and reduce the risk of rejection following regulatory approval. This global approach to mitigate the risk of post-regulatory rejection follows a successful proof of concept pilot undertaken in Ontario since 2012 of 11 medical technologies through MaRS EXCITE.
Often companies regard regulatory approval as the largest hurdle to get to market, but this is only the first stop in a long and complicated pathway to technology adoption. Multiple payers and health systems need to be convinced about the value add of the technology before making a decision whether to adopt. Until now, these important stakeholders have been excluded from the early stages of evaluation and are approached late in a process that all too-often fails to meet their expectations. This results in rejection rates for regulatory-approved technologies as high as ninety-five percent.
The EXCITE approach offers a clear large-scale alternative to the existing post-market health technology assessment by working collaboratively to pull rather than push impactful technologies into health systems.
Presenters will include:
- Joe Gatewood, Vice President for Global Strategy and Analysis, AdvaMed
- Dr. Leslie Levin, Chief Executive and Scientific Officer, EXCITE International
- Dr. Naomi Aronson, Chair of EXCITE Payers’ Advisory Committee and Executive Director Clinical Evaluation, Innovation, and Policy Office of Clinical Affairs Blue Cross Blue Shield Association
- Dr. Bryan Luce, Chair of EXCITE Scientific Collaboration and Senior Advisor Evidera and immediate past Chief Scientific Officer, PCORI
1:30 p.m until 3:30 p.m EST
In-Person Registrant Logistics:
701 Pennsylvania Avenue NW
Washington, DC 20004
Virtual Registrant Logistics:
Login and dial-in details for virtual registants will be sent within 24 hours of the event.
For more information including an EXCITE International application form , please visit www.exciteinternational.com. If you have questions about the content and agenda for the event, please contact Joe Gatewood at JGatewood@advamed.org. For any questions abtout registration, please email Nancy Jackon at email@example.com.